Cross-talk between cancer-initiating cells and immune cells: considerations for combination therapies
Ann Transl Med
.
2016 Oct;4(Suppl 1):S56.
doi: 10.21037/atm.2016.10.30.
Authors
Amy S Codd
1
,
Saly Al-Taei
1
,
Zsuzsanna Tabi
1
Affiliation
1
Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, CF14 2TL, UK.
PMID:
27868024
PMCID:
PMC5104641
DOI:
10.21037/atm.2016.10.30
No abstract available
Publication types
Comment